Markets · bedrock market · provisional

Cell & Gene Therapy

Regulated market (fda / ema approved cell and gene therapy products) + trial participation + trade-body membership. The Kin Score Market layer reads each provider in its market: who it integrates with, how deep those integrations go, and where the market publishes its own structure. Methodology.

32providers measured
0 (0.0%)declare their own
17 (53.1%)covered by others only
15 (46.9%)undeclared
0in-market workflows shown
Provisional. Provisional and unweighted: the Market layer is not part of the composite or agent readiness. Leader lists are read within a position, never as one ranking. A provider that declares nothing we can read is shown as undeclared, with no number: we never infer integrations.

Where this market publishes its structure

Own = declares at least one integration itself; covered = visible only because an aggregator, standards body, regulator or partner contract names it; distribution-only = listed only on cloud marketplaces it sells through, a channel reported beside, never counted as its own declared integrations; undeclared = nothing we can read, so no number; declares_compatibility = providers with a `compatible` shape vote, report only (kin, 2026-10-13): never counted as own, never in depth or position.

Taxonomy how this market maps onto apis.io

Derived 2026-10-21 from the 32 providers in this market we could resolve in the catalog. The percentage is the share of those providers carrying each one; it describes the market, not the tag or industry. Tag groups have no page of their own yet, so they are listed unlinked.

TagsBiotechnology 88%, Life Sciences 81%, Pharmaceuticals 44%, Clinical Trials 38%, Gene Therapy 38%, Cell Therapy 31%, Healthcare 28%, Oncology 22%, Rare Disease 22%
Tag groupsHealthcare 91%, Gene Therapy 53%, Cell Therapy 31%, Rare Disease 31%
IndustriesBiotechnology & Drug Discovery 91%, Life Sciences 81%, Pharmaceutical 53%, Healthcare 34%

share of resolved cohort carrying it; tags >=0.20 & >=3 members (max 12, junk dropped), tag_groups >=0.20 (cooccurrence, non-cross-cutting; max 8), industries >=0.20 (max 6), areas >=0.10 (max 6; areas are keyword-matched and sparse), capabilities L1 >=0.20 (max 8); derive-market-taxonomy.py

Leaders by position (provisional)

Provisional: grouped by position, depth compared within a position only. Distribution (cloud marketplaces) and iPaaS bridges are counted beside position, never inside it. Unknown-builder listings are left out of position shares and counted here.

regulated 5 · named in a regulator's register or partners' contracts

ProviderDepthIntegrationsIn / outUnknown builderDistributioniPaaS bridgeMix
Autolus 65.2 4 0 / 4 0 0 0 contract 50%, standard 50%
Vertex Pharmaceuticals 52.5 thin 2 0 / 2 0 0 0 contract 100%
Celgene 43.5 thin 2 0 / 2 0 0 0 contract 50%, standard 50%
Pfizer 43.5 thin 2 0 / 2 0 0 0 contract 50%, standard 50%
Spark Therapeutics 43.5 thin 2 0 / 2 0 0 0 contract 50%, standard 50%

standard 12 · listed by a voluntary standard's own directory

ProviderDepthIntegrationsIn / outUnknown builderDistributioniPaaS bridgeMix
Novartis 60.7 3 0 / 3 0 0 0 contract 33%, standard 67%
Regeneron 60.7 3 0 / 3 0 0 0 contract 33%, standard 67%
iECURE 34.5 thin 2 0 / 2 0 0 0 standard 100%
Arbor Biotechnologies 17.2 thin 1 0 / 1 0 0 0 standard 100%
Ascend Advanced Therapies 17.2 thin 1 0 / 1 0 0 0 standard 100%
Asimov 17.2 thin 1 0 / 1 0 0 0 standard 100%
Atsena Therapeutics 17.2 thin 1 0 / 1 0 0 0 standard 100%
Catalent 17.2 thin 1 0 / 1 0 0 0 standard 100%
Code Biotherapeutics 17.2 thin 1 0 / 1 0 0 0 standard 100%
Dyno 17.2 thin 1 0 / 1 0 0 0 standard 100%
Kriya Therapeutics 17.2 thin 1 0 / 1 0 0 0 standard 100%
Life Biosciences 17.2 thin 1 0 / 1 0 0 0 standard 100%

undeclared 15 · declares nothing we can read: no number

ProviderDepthIntegrationsIn / outUnknown builderDistributioniPaaS bridgeMix
3T Biosciences undeclared-----
A2 Biotherapeutics undeclared-----
AAVantgarde Bio undeclared-----
Alloplex Biotherapeutics undeclared-----
American Gene Technologies undeclared-----
CUTISS undeclared-----
Elegen undeclared-----
Gameto undeclared-----
Genscript Probio undeclared-----
KSQ Therapeutics undeclared-----
PBS Biotech undeclared-----
Slingshot Biosciences undeclared-----
Synthego undeclared-----
Tune Therapeutics undeclared-----
Wugen undeclared-----

Generated 2026-10-21 from API Evangelist's own files; nothing on this page is a model's judgement. Provisional and unweighted; not part of the Kin Score composite or agent readiness. Read the Market layer methodology. Disagree with an edge? Every edge cites its evidence and can be corrected through the normal correction path.